NEW YORK (GenomeWeb) – RayBiotech today announced a partnership with XCellCure to develop a cardiovascular disease diagnostic kit.

The firms will co-market and co-distribute the kits worldwide with a focus initially on the research market and the longer term goal of making the technology available to the clinical diagnostics and prognostics spaces.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.